ABSTRACT
Introduction Transcranial alternating current stimulation (tACS) at 5-Hz to the right hemisphere can effectively alleviate symptoms of anxiety. The objective of this study was to explore the neural mechanisms that drive the therapeutic benefits.
Methods We collected electroencephalography (EEG) data from 24 participants with anxiety disorders both before and after the tACS treatment during a single session. We applied the stimulation over the right hemisphere, with 1.0 mA at F4, 1.0 mA at P4, and 2.0 mA at T8, following the 10-10 EEG convention. With eLORETA, we transformed the scalp signals into the current source density in the cortex. We then assessed the differences between post- and pre-treatment brain maps across multiple spectra (delta to low gamma) with non-parametric statistics.
Results We observed a trend of heightened power in alpha and reduced power in mid-to-high beta and low gamma, in accord with the EEG markers of anxiolytic effects reported in previous studies. Additionally, contrary to the widely circulated entrainment theory of the neural effects of tACS, we observed a consistent trend of de-synchronization at the stimulating sites across spectra.
Conclusion We confirmed that tACS 5-Hz over the right hemisphere demonstrated EEG markers of anxiety reduction. Regarding changes in power spectra, the effects of tACS on the brain are intricate and cannot be explained solely by entrainment theory.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No research fund
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee of Pearl IRB gave ethical approval for this work (category: exempt because the study is about analyzing record data)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Email addresses for the other author: TW Lee: dwleeibru{at}gmail.com CSR Li: chiang-shan.li{at}yale.edu
Data Availability
All data produced in the present study are available upon reasonable request to the authors
